1. Cardiovascular Toxicity of Targeted Therapies for Cancer: An Overview of Systematic Reviews
   Marina T Van Leeuwen et al, 2020, JNCI Cancer Spectrum CrossRef
2. Methodological quality evaluation of systematic reviews or meta-analysis of trastuzumab-based therapy for breast cancer
   Hua Wei et al, 2021, Medicine CrossRef
3. Cytostatic Agents: Monoclonal Antibodies Utilized in the Treatment of Solid Malignancies
   David Reeves, 2017, A Worldwide Yearly Survey of New Data in Adverse Drug Reactions CrossRef
4. The Value of Neoadjuvant Anthracycline-Based Regimens for HER2-Positive Breast Cancer: A Systematic Review and Meta-analysis Including 1366 Patients
   Yuqin Ding et al, 2023, Clinical Medicine Insights: Oncology CrossRef
5. Risk of gastrointestinal complications in breast cancer patients treated with neratinib: a meta-analysis
   Nan Jiang et al, 2017, Expert Opinion on Drug Safety CrossRef
6. Dual targeting of HER2-positive breast cancer with trastuzumab emtansine and pertuzumab: understanding clinical trial results
   Alberto Ocaña et al, 2018, Oncotarget CrossRef
7. Appraising the quality of meta-analysis for breast cancer treatment in the adjuvant setting: A systematic review
   Pablo Mandó et al, 2021, Cancer Treatment and Research Communications CrossRef